Cite
HARVARD Citation
Plantinga, T. et al. (2017). Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' Disease. Clinical pharmacology & therapeutics. 102 (6), pp. 1017-1024. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Plantinga, T. et al. (2017). Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' Disease. Clinical pharmacology & therapeutics. 102 (6), pp. 1017-1024. [Online].